Press
Back to Press

Physicians' Education Resource® to Offer EACCME® Accreditation for European Biosimilars Live Webcast

Expert faculty to join co-chairs during live webcast

CRANBURY, N.J.--Physicians’ Education Resource® (PER®), the leading educational resource for oncology and hematology continuing medical education (CME), will offer accreditation from the European Accreditation Council for Continuing Medical Education Institution (EACCME®) during the live video webcast, “Advent of Oncology Monoclonal Antibody Biosimilars – A European Perspective.” The webcast will take place on Oct. 27, at 2 p.m. GMT.“We are thrilled to offer our attendees CME credits from EACCME® during this highly engaging and informative webcast,” said Phil Talamo, president, PER®. “This virtual, state-of-the-art webcast will serve as a platform to bring together some of the topmost oncology leaders from throughout the world. We look forward to discussing the development of biosimilars in conjunction to oncology, hematology and cancer treatment, with a European perspective.”

Founded in 1999, EACCME® is a product of the European Union of Medical Specialists. It offers international accreditation for CME activities, events, programs and e-learning materials. EACCME®’s mission to monitor and offer quality international CME programs directed at the international audience of medical professionals including physicians, nurses and researchers.

In addition to the accreditation, PER® welcomes two new faculty members, Dr. Antonio Llombart, M.D., Ph.D., co-Founder, Medica Scientia Innovation Research (MedSIR ARO), chairman, medical oncology Service, Hospital Arnau de Vilanova de Valencia, Valencia, Spain; and Matthew J. Matasar, M.D., medical oncologist, Memorial Sloan Kettering Cancer Center, New York City, New York. The extraordinary faculty members will join the co-chairs in sharing their expertise during the educational panel discussion.

For more information, please visit www.gotoper.com/conferences/eurobio/meetings/live-video-webcast-advent-of-oncology-monoclonal-antibody-biosimilars-a-european-perspective.

About PER®:

Since 1995, Physicians’ Education Resource® (PER®) has been the leading provider of live, online and print CME activities focusing on oncology and hematology by providing high-quality, evidence-based activities featuring leading experts who focus on the application of practice-changing advances. In 2017, PER® will develop and implement 21 historic annual legacy conferences in the Unites States and Europe, along with many world-renowned online learning formats. PER® is also the publisher of the monthly peer-reviewed American Journal of Hematology/Oncology® and is accredited by the Accreditation Council for Continuing Medical Education and the California Board of Registered Nurses. PER® is part of the Cranbury, New Jersey-based Michael J. Hennessy Associates, Inc. family of businesses. Learn more at www.gotoper.com and www.mjhassoc.com.

 

Contacts

PER® Media:
Theresa Burek, 609-716-7777 ext. 811
tburek@mjhassoc.com
or
Surabhi Verma, 609-716-7777 ext. 851
sverma@mjhassoc.com



Back to Press








Become a Member

Forgot Password?
Filter By